Groundbreaking bowel cancer trial follow-up shows zero relapses

A groundbreaking bowel cancer trial follow-up reported zero relapses among participants, marking a significant advancement in cancer treatment. The results suggest potential long-term remission for patients, offering hope for improved survival rates.